Related Experiment Videos
Churg-Strauss syndrome and pregnancy: successful treatment with intravenous immunoglobulin
Samara Amaris Rutberg1, David E Ward, Bernard J Roth
1Department of Internal Medicine, Madigan Army Medical Center, Tacoma, WA 98431, USA. srutberg@excite.com
Abstract:
Churg-Strauss syndrome is an extremely rare disease, and even less common in women of childbearing age. The initial management of Churg-Strauss syndrome consists of high doses of corticosteroids. Patients with severe disease, or those who are unresponsive to corticosteroids, usually are treated with cytotoxic drugs. Intravenous immunoglobulin (IVIg) has become a promising, but not completely accepted, form of treatment for systemic vasculitis that is unresponsive to standard therapy. We present a case of a woman diagnosed with Churg-Strauss syndrome that was refractory to corticosteroid and cyclophosphamide treatment. When she was found to be 3 months pregnant, treatment with IVIg was instituted with successful results. This case not only supports the beneficial effect of IVIg in Churg-Strauss syndrome, it illustrates its successful use in a patient who was pregnant.
Related Concept Videos
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Respiratory Syncytial Virus Disease
Streptococcal Pharyngitis
American Trypanosomiasis
Angle Closure Glaucoma: Treatment